CANTALOUPE is a Percutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Alk-abello, Inc.. The primary component is Cantaloupe.
| Product ID | 0268-6115_3df12f87-12d7-4d3f-83c0-209927a6088a |
| NDC | 0268-6115 |
| Product Type | Non-standardized Allergenic |
| Proprietary Name | CANTALOUPE |
| Generic Name | Cantaloupe |
| Dosage Form | Injection, Solution |
| Route of Administration | PERCUTANEOUS |
| Marketing Start Date | 1965-01-01 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103753 |
| Labeler Name | ALK-Abello, Inc. |
| Substance Name | CANTALOUPE |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Fruit Proteins [EXT] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1965-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA103753 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1965-01-01 |
| Marketing Category | BLA |
| Application Number | BLA103753 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Billing Unit | ML |
| Marketing Start Date | 1998-02-23 |
| Ingredient | Strength |
|---|---|
| CANTALOUPE | .1 g/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0268-6115 | CANTALOUPE | Cantaloupe |
| 36987-1306 | Cantaloupe | Cantaloupe |
| 36987-1307 | Cantaloupe | Cantaloupe |
| 36987-1308 | Cantaloupe | Cantaloupe |
| 36987-1309 | Cantaloupe | Cantaloupe |
| 49288-0102 | Cantaloupe | Cantaloupe |
| 54575-360 | CANTALOUPE | cantaloupe |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CANTALOUPE 90522851 not registered Live/Pending |
USA Technologies 2021-02-10 |
![]() CANTALOUPE 77454234 3540143 Dead/Cancelled |
Cantaloupe LLC 2008-04-22 |
![]() CANTALOUPE 75395038 2371481 Dead/Cancelled |
KARYS, INC. 1997-11-24 |